ArticleHaematologica2022

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.

Alberto J Arribas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.